The Norwegian Drug Monitoring Study

NACompletedINTERVENTIONAL
Enrollment

611

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

December 14, 2020

Study Completion Date

December 14, 2020

Conditions
Rheumatoid ArthritisSpondyloarthritisAnkylosing SpondylitisCrohn DiseaseUlcerative ColitisPsoriasisPsoriatic Arthritis
Interventions
OTHER

Therapeutic drug monitoring

Treatment algorithm based on assessments of serum drug levels and anti-drug antibodies

OTHER

Standard care

Treatment algorithm based on standard clinical assessments, without knowledge of serum drug levels and anti-drug antibodies

Trial Locations (21)

1478

Akershus University Hospital, Oslo

1535

Sykehuset Østfold Moss, Moss

Unknown

Sørlandet Sykehus, Arendal, Arendal

Ålesund, HELSE MØRE OG ROMSDAL HF, Ålesund

Haukeland, HELSE BERGEN HF,, Bergen

Bodø, NORDLANDSSYKEHUSET, Bodø

Drammen, VESTRE VIKEN HF, Drammen

Elverum, SYKEHUSET INNLANDET HF, Elverum

Helse Førde Hf, Førde

Hamar, SYKEHUSET INNLANDET HF, Hamar

HAUGESUND SANITETSFORENING revmatismesykehus, Haugesund

Haugesund Sjukehus, Haugesund

SØRLANDET SYKEHUS HF Kristiansand, Kristiansand

REVMATISMESYKEHUSET AS, Lillehammer, Lillehammer

Betanien Hospital, Skien

Stavanger Universitetssjukehus, Stavanger

Tromsø, UNIVERSITETSSYKEHUSET NORD-NORGE HF, Tromsø

St Olavs Hospital, Trondheim

Sykehuset Vestfold, Tønsberg, Tønsberg

0372

Rikshospitalet, Oslo

0687

Diakonhjemmet Sykehus, Oslo

All Listed Sponsors
collaborator

Oslo University Hospital

OTHER

collaborator

University Hospital, Akershus

OTHER

lead

Diakonhjemmet Hospital

OTHER

NCT03074656 - The Norwegian Drug Monitoring Study | Biotech Hunter | Biotech Hunter